ESAR - European Surveillance of Antibiotic Resistance
All Alert isolates
Alert Organisms by phenotype, Total and Percent resistant

Total
  All centers Aberdeen Leipzig Bratislava (St. El.) Bratislava (NCI) Warsaw
Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant Isolates Tested Resistant
N % N % N % N % N % N %
Organism Phenotype 13267 274 2.07 7208 112 1.55 875 8 0.91 302 22 7.28 4544 123 2.71 338 9 2.66
Beta-haemolytic Streptococci Macrolide
Glycopeptide 13267 1 0.01 7208 0 0.00 875 1 0.11 302 0 0.00 4544 0 0.00 338 0 0.00
Penicillin 13267 6 0.05 7208 1 0.01 875 4 0.46 302 0 0.00 4544 1 0.02 338 0 0.00
Pneumococci Macrolide 5848 214 3.66 1177 33 2.80 159 3 1.89 27 3 11.11 4249 167 3.93 236 8 3.39
Glycopeptide 5848 0 0.00 1177 0 0.00 159 0 0.00 27 0 0.00 4249 0 0.00 236 0 0.00
High level Penicllin 5848 3 0.05 1177 0 0.00 159 0 0.00 27 0 0.00 4249 2 0.05 236 1 0.42
Low level Penicillin 5848 346 5.92 1177 9 0.76 159 0 0.00 27 3 11.11 4249 316 7.44 236 18 7.63
Enterococci Beta-lactamase positive 23299 249 1.07 10293 0 0.00 2820 90 3.19 370 16 4.32 8695 138 1.59 1121 5 0.45
Glycopeptide 23299 24 0.10 10293 1 0.01 2820 10 0.35 370 1 0.27 8695 2 0.02 1121 10 0.89
High level aminoglycoside 23299 951 4.08 10293 0 0.00 2820 537 19.04 370 17 4.59 8695 196 2.25 1121 201 17.93
Haemophilus Beta-lactamase positive 11036 362 3.28 1980 82 4.14 433 0 0.00 146 6 4.11 8036 269 3.35 441 5 1.13
Ceftazidime/3rd or 4th generation cephalosporin 11036 0 0.00 1980 0 0.00 433 0 0.00 146 0 0.00 8036 0 0.00 441 0 0.00
Ciprofloxacin/4-fluoroquinolone 11036 0 0.00 1980 0 0.00 433 0 0.00 146 0 0.00 8036 0 0.00 441 0 0.00
Enterobacteriaceae Carbapenem 94086 23 0.02 50480 4 0.01 6288 10 0.16 1543 0 0.00 32552 9 0.03 3223 0 0.00
Ciprofloxacin/4-fluoroquinolone 94086 2278 2.42 50480 757 1.50 6288 314 4.99 1543 58 3.76 32552 967 2.97 3223 182 5.65
Extended spectrum beta-lactamase positive 94086 582 0.62 50480 2 0.00 6288 176 2.80 1543 28 1.81 32552 286 0.88 3223 90 2.79
Gentamicin 94086 1945 2.07 50480 189 0.37 6288 226 3.59 1543 44 2.85 32552 1180 3.62 3223 306 9.49
Acinetobacter Carbapenem 4778 20 0.42 1316 0 0.00 398 6 1.51 79 2 2.53 2430 8 0.33 555 4 0.72
Gentamicin 4778 799 16.72 1316 1 0.08 398 16 4.02 79 20 25.32 2430 628 25.84 555 134 24.14
Staphylococcus aureaus Total Methicillin 55148 2055 3.73 25240 1580 6.26 3038 64 2.11 416 6 1.44 23525 305 1.30 2929 100 3.41
Teicoplanin 55148 0 0.00 25240 0 0.00 3038 0 0.00 416 0 0.00 23525 0 0.00 2929 0 0.00
Vancomycin 55148 1 0.00 25240 0 0.00 3038 1 0.03 416 0 0.00 23525 0 0.00 2929 0 0.00
Cholera Tetracycline/Doxycycline 8 0 0.00 0 0 - 0 0 - 0 0 - 8 0 0.00 0 0 -
Trimethoprim 8 0 0.00 0 0 - 0 0 - 0 0 - 8 0 0.00 0 0 -
Campylobacter Ciprofloxacin 3174 189 5.95 2897 189 6.52 15 0 0.00 0 0 - 250 0 0.00 12 0 0.00
Shigella Ciprofloxacin 530 0 0.00 37 0 0.00 7 0 0.00 0 0 - 486 0 0.00 0 0 -
Salmonella Ciprofloxacin 3836 2 0.05 831 2 0.24 84 0 0.00 8 0 0.00 2913 0 0.00 0 0 -
Neisseria meningitidis Penicillin 144 1 0.69 88 1 1.14 0 0 - 0 0 - 26 0 0.00 30 0 0.00
Neisseria gonorrhoea Beta-lactamase positive 217 12 5.53 198 8 4.04 1 0 0.00 0 0 - 18 4 22.22 0 0 -
Ciprofloxacin/4-fluoroquinolone 217 12 5.53 198 12 6.06 1 0 0.00 0 0 - 18 0 0.00 0 0 -
Anaerobes Augmentin/beta-lactamase inhibitor combination 13098 14 0.11 10580 14 0.13 739 0 0.00 67 0 0.00 1712 0 0.00 0 0 -
Carbapenem 13098 0 0.00 10580 0 0.00 739 0 0.00 67 0 0.00 1712 0 0.00 0 0 -
Metronidazole 13098 17 0.13 10580 0 0.00 739 0 0.00 67 12 17.91 1712 5 0.29 0 0 -
Coagulase negative Staphylococci Teicoplanin 25942 5 0.02 16919 1 0.01 2080 4 0.19 307 0 0.00 6636 0 0.00 0 0 -
Vancomycin 25942 1 0.00 16919 0 0.00 2080 0 0.00 307 0 0.00 6636 1 0.02 0 0 -
Pseudomonas aeruginosa Ceftazidime/4th generation cephalosporin 17213 516 3.00 7638 52 0.68 1450 50 3.45 235 13 5.53 6978 346 4.96 912 55 6.03
Gentamicin 17213 1902 11.05 7638 67 0.88 1450 162 11.17 235 48 20.43 6978 1490 21.35 912 135 14.80
Piperacillin/Tazobactam 17213 550 3.20 7638 41 0.54 1450 67 4.62 235 4 1.70 6978 394 5.65 912 44 4.82

ESBiC Study Center